Stem cell therapy is a promising area for future research in pain medicine utilising mesenchymal stem cells which have the ability to transform (Pluripotency). Mesenchymal stem cell were initially harvested from bone marrow to treat blood disorders. These cells have now been identified as possible treatment options for patients with chronic pain. The uniqueness is te cells ability to transform and also is freely accessible in adipose tissue ( fat cells). This makes this therapy safe and minimally invasive.
Which patient are suitable for SCT?
Patients who have failed conservative management may consider this therapy. The results from clinical research is mixed with no strong recommendations. This is an area of ongoing research, SCT is usually considered when pain limits function significantly and other treatments have failed.
Some conditions which SCT have been studied are
Is SCT Safe?
SCT is a minimally invasive therapy which is well tolerated by patients. There are no major drawbacks as the cells are extracted from adipose tissue (fat cells) or blood drawn from oneself. The complications, if they arise, are usually related to the injection approach to the site, which will be explained by your doctor. Many patients looking for the best stem cell treatment in Sydney choose SCT for its safety, effectiveness, and natural healing potential.
©2025 PainMed. All Rights Reserved. Built by Clickmatix – Digital Marketing & Web Experts
Originally from England, Sally graduated from St George’s Hospital, University of London in 2004 with a BSc (First Class Hons) in Physiotherapy. Since settling in Australia, Sally has worked in private practice and in the public hospital setting across Sydney.
Sally gained a Masters in Medicine Pain Management from the University of Sydney in 2019 and is a Titled Pain Physiotherapist (as awarded by the Australian Physiotherapy Association).
In addition to private practice, Sally currently works as a Senior Physiotherapist at Westmead Hospital Pain Management Service.
Sally is highly skilled in assessing, diagnosing and treating people who experience chronic pain. She enjoys working with injured workers and CTP claimants. She has a deep understanding of the impact of pain on the whole person and on their functioning in daily life. In partnership with her colleagues, Sally enjoys applying her knowledge and clinical skills to provide a safe space for exploration of the physical and emotional meaning of pain and for recovery of function.
Qualifications and Experience
Dr. Adam is a Fellowship-trained Pain Medicine Specialist with a Fellowship from the Faculty of Pain Medicine (FFPMANZCA) and a Master of Pain Medicine from the University of Sydney. He is dedicated to the comprehensive management of chronic pain across all age groups.
Dr. Adam trained in adult pain medicine at Liverpool Hospital, Nepean Hospital, and the Department of Pain Medicine, and completed additional training in paediatric chronic pain at The Children’s Hospital at Westmead. He currently serves as a Staff Specialist at Westmead and St George Public Hospitals (NSW Health), and is a Visiting Medical Officer (VMO) at Liverpool Public Hospital, St George Private, Sydney Southwest Private, Holroyd Private, Norwest Private, and Nepean Private Hospitals.
He adopts a whole-person, multidisciplinary approach rooted in the socio-psycho-biomedical model, utilising both pharmacologic and interventional techniques. These include:
Dr. Adam is an Authorised Prescriber of Medicinal Cannabis and holds a Diploma in Medicinal Cannabis. He is also certified in Opioid Treatment Programs, including Methadone. His areas of interest include opioid dependence management, medicinal cannabis, and interventional pain procedures.
He also completed advanced training in Virtual Reality Therapy for chronic pain and mental health disorders in Barcelona, Spain, and has further qualifications in Focused Psychological Strategies, Cognitive Behavioural Therapy (CBT), and Clinical Hypnosis.
Qualifications:
